APPLICATION
ANDA074558
TYPE
ANDA
ORIGINAL APPROVAL
1996-08-15
LATEST ACTION
2024-12-26
ROUTE
ORAL
DOSAGE FORM
POWDER
MARKETING STATUS
Prescription
Products
CHOLESTYRAMINE LIGHTPrescription
CHOLESTYRAMINE EQ 4GM RESIN/SCOOPFUL · POWDER · ORAL
CHOLESTYRAMINE LIGHTPrescription
CHOLESTYRAMINE EQ 4GM RESIN/PACKET · POWDER · ORAL
Approval history
2024-12-26Manufacturing (CMC) · Supplement 14 · unknownAP
2000-02-02Manufacturing (CMC) · Supplement 4AP
1998-05-27Manufacturing (CMC) · Supplement 2AP
1998-02-13Labeling · Supplement 3AP
1996-10-08Labeling · Supplement 1AP
1996-08-15OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.